| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | Director | Common Stock | 10.8K | $292K | $27.06 | Aug 13, 2024 | Direct |
| EXELIXIS, INC. | Director | Option (right to buy) | 20K | May 31, 2024 | Direct | ||
| Stoke Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 7.64K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | Aug 13, 2024 | 1 | $0 | 4 | Aug 15, 2024 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| EXEL | EXELIXIS, INC. | May 31, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| EXEL | EXELIXIS, INC. | May 21, 2024 | 1 | -$576K | 4 | May 23, 2024 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| EXEL | EXELIXIS, INC. | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| EXEL | EXELIXIS, INC. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
| EXEL | EXELIXIS, INC. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |